BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Feb 14, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Tamiflu oseltamivir regulatory update

Gilead received a Paragraph IV certification letter indicating that Natco Pharma Ltd. (BSE:NATCO; NSE:NATCOPHARM, Hyderabad, India) submitted an ANDA to FDA for a generic...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >